Katabi Maha
SEC CIK 1720685 · EDGAR
BoughtSold
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
Katabi Maha made no open-market trades at VERA in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-03-25 | 2024-03-21+ | VERA | Vera Therapeutics, Inc. | Katabi Maha | Dir | S - Sale | $40.86 | -834.5K | 2.79M | -23% | -$34.10M |
| I | 2024-02-01 | 2024-01-30 | VERA | Vera Therapeutics, Inc. | Katabi Maha | Dir | P - Purchase | $31.00 | +161.3K | 3.63M | +5% | +$5.00M |
| 2022-02-14 | 2022-02-10 | VERA | Vera Therapeutics, Inc. | Katabi Maha | Dir, 10% | P - Purchase | $15.00 | +266.7K | 3.18M | +9% | +$4.00M | |
| DI | 2021-07-06 | 2021-07-02 | JBIO | Jade Biosciences, Inc. | Katabi Maha | Dir, 10% | C - Cnv Deriv | — | +3.40M | 3.40M | New | — |
| DI | 2021-07-06 | 2021-07-02 | JBIO | Jade Biosciences, Inc. | Katabi Maha | Dir, 10% | P - Purchase | $14.00 | +357.1K | 3.76M | +10% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations